Kuwait vs Moldova: Cause of death, by non-communicable diseases, ages 5-14, male
Kuwait
47.7%
in 2021
Moldova
48.0%
in 2021
Kuwait rank
57th
Moldova rank
55th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Kuwait
- Moldova
How they compare
Moldova currently reports 48.0% against 47.7% in Kuwait, a difference of 0.3%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Kuwait ahead.
Kuwait ranks 57th and Moldova ranks 55th of 185 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.4% | 30.8% | 14.7% | Kuwait |
| 2010s | 45.5% | 39.4% | 6.2% | Kuwait |
| 2020s | 47.2% | 44.2% | 3.0% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Kuwait or Moldova?
- Moldova, at 48.0% against 47.7% in Kuwait as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Kuwait and Moldova?
- 0.3%, with Moldova ahead.
- How many years of comparable data are there for Kuwait and Moldova?
- 6 years are reported by both, from 2000 to 2021.
- How do Kuwait and Moldova rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Kuwait ranks 57th and Moldova ranks 55th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.